drugset / Trial / NCT06075030
A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy
RandomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and efficacy of AND017 after 6 weeks of treatment in patients with cancer-related anemia who are receiving chemotherapy.
Timeline
- Start
- 2027-12
- Primary completion
- 2027-12
- Completion
- 2028-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AND017 | Unknown | — | Oral |